• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 4-(thiophene-2-sulfonamido)butanoic acid (CAS No. 379251-18-0)

4-(thiophene-2-sulfonamido)butanoic acid, identified by the chemical compound code CAS No. 379251-18-0, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound belongs to the class of sulfonamides, which are widely recognized for their diverse biological activities and therapeutic potential. The structural integration of a thiophene-2-sulfonamido moiety with a butanoic acid backbone imparts unique chemical and pharmacological properties, making it a subject of intense study in medicinal chemistry.

The thiophene ring, a five-membered heterocyclic aromatic structure, is known for its stability and ability to interact with biological targets in complex ways. When combined with a sulfonamide group, the resulting molecule can exhibit enhanced solubility and binding affinity to specific enzymes or receptors. This characteristic has positioned 4-(thiophene-2-sulfonamido)butanoic acid as a promising candidate for drug development, particularly in the treatment of inflammatory diseases, infectious disorders, and metabolic conditions.

In recent years, advancements in computational chemistry and high-throughput screening have facilitated the rapid identification of novel sulfonamide derivatives with therapeutic potential. Studies have demonstrated that compounds containing the thiophene-2-sulfonamido moiety can modulate various biological pathways by inhibiting key enzymes or disrupting protein-protein interactions. For instance, research has shown that derivatives of this class can exhibit anti-inflammatory effects by targeting cyclooxygenase (COX) enzymes or interleukin pathways, which are critical in mediating inflammatory responses.

The butanoic acid component of the molecule contributes to its pharmacokinetic profile, influencing factors such as absorption, distribution, metabolism, and excretion (ADME). This segment can enhance the compound's bioavailability while also providing a site for further functionalization to optimize its pharmacological activity. The combination of these structural elements makes 4-(thiophene-2-sulfonamido)butanoic acid (CAS No. 379251-18-0) a versatile scaffold for medicinal chemists seeking to develop next-generation therapeutics.

Recent experimental studies have highlighted the compound's potential in addressing neurodegenerative diseases. The sulfonamide group is known to interact with amino acid residues in target proteins, potentially leading to the development of neuroprotective agents. Preliminary data suggest that 4-(thiophene-2-sulfonamido)butanoic acid can attenuate oxidative stress and inflammation associated with conditions like Alzheimer's disease and Parkinson's disease. These findings underscore the importance of exploring sulfonamide-based compounds as candidates for neuroprotective therapies.

The synthesis of 4-(thiophene-2-sulfonamido)butanoic acid involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Key synthetic routes typically involve the coupling of thiophene derivatives with sulfonamide precursors followed by functional group transformations to introduce the butanoic acid moiety. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to conduct extensive pharmacological evaluations.

In conclusion, 4-(thiophene-2-sulfonamido)butanoic acid (CAS No. 379251-18-0) represents a significant advancement in pharmaceutical research due to its unique structural features and promising biological activities. The integration of a thiophene-2-sulfonamido group with a butanoic acid backbone provides a robust framework for developing novel therapeutics targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug discovery and development efforts worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)